From: Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approaches
Parameter
BUD
AZL
Proposed method
Comparison method [13]
Comparison method [40]
\(\overline{\text{X}}\) ± SD
100.29 ± 0.75
99.95 ± 1.36
99.85 ± 0.84
99.61 ± 0.98
t-value
0.58 (1.81)
0.45 (1.81)
F-value
3.28 (4.35)
1.37 (4.35)